IP Library › Granted Patent US 7,049,420
Granted Patent B2
US 7,049,420 · App. 10/311,591 · Granted May 23, 2006

Regulation of human prostasin-like serine protease

Assignee: Bayer HealthCare AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,049,420
App. No.
10/311,591
Granted
May 23, 2006
Kind
B2
Abstract

Reagents which regulate human prostasin-like enzyme activity and reagents which bind to human prostasin-like enzyme gene products can be used to regulate human prostasin-like enzyme activity. Such regulation is particularly useful for treating metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.

Claims (10)

1. An isolated and purified polynucleotide which encodes the amino acid sequence as shown in SEQ ID NO: 6.

2. The polynucleotide of claim 1 which comprises the nucleotide sequence as shown in SEQ ID NO: 5.

3. The polynucleotide of claim 1 which is a cDNA.

4. An expression construct, comprising; a coding sequence for the amino acid sequence as shown in SEQ ID NO: 6; and a promoter which is located upstream from the coding sequence and which controls expression of the coding sequence.

5. The expression construct of claim 4 wherein the coding sequence comprises a nucleotide sequence as shown in SEQ ID NO:5.

6. An isolated host cell comprising an expression construct, wherein the expression construct comprises:

a coding sequence for a protein comprising the amino acid sequence as shown in SEQ ID NO: 6; and a promoter which is located upstream from the coding sequence and which controls expression of the coding sequence.

7. The host cell of claim 6 which is prokaryotic.

8. The host cell of claim 6 which is eukaryotic.

9. A method of producing a protein, comprising the steps of: culturing a host cell in a culture medium, wherein the host cell comprises an expression construct comprising (1) a coding sequence for a protein comprising an the amino acid sequence as shown in SEQ ID NO: 6 and (b) a promoter which is located upstream from the coding sequence and which controls expression of the coding sequence, wherein the step of culturing is carried out under conditions whereby the protein is expressed; and recovering the protein.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2013
From: BAYER PHARMA AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029839/0959 →
CHANGE OF NAME Recorded Oct 18, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029150/0303 →
MERGER Recorded Feb 19, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022277/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2006
From: BAYER AKTIENGESELLSCHAFT
To: BAYER HEALTHCARE AG
Reel/Frame 017140/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2002
From: XIAO, YONGHONG
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 013769/0616 →
Continuity (3)
Provisional Application 6027761200 · Mar 22, 2001
Provisional Application 6021347400 · Jun 23, 2000
Related Publication 20040141962A1 · Jul 22, 2004